Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds - 2Surging measles cases are 'fire alarm' warning that other diseases could be next
- 3Island Travel Guide: Must-Visit Objections for 2024
- 4The Longest Underwater Tunnel Connecting Germany and Denmark
- 5Want to be better about saving money in 2026? Try these money-saving tips for having a ‘low-buy’ January and beyond
- High Court weighs Assenheim appeal over release of Feldstein interview raw footage
- High-Suggested Broilers For Your Homes
- Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink
- Best bar-b-que Style: Which One Is Your Number one?
- Which Diet Prompts the Incomparable Wellbeing Results?
- The Main 15 Powerful Business Heads of Today
- Iran war upends aviation strategies
- Satellite data reveals a huge solar storm in 2024 shrank Earth's protective plasma shield
- NASA says Maven spacecraft that was orbiting Mars has gone silent
